After decades of scientific suppression, a handful of intrepid researchers have pushed through major barriers to examine the power of psychedelic therapy to treat the ailing human mind. Their research has recovered a path towards a particularly deep quality of care and healing.
The timeliness of these advances cannot be overstated. Over half a billion people on our planet are suffering from the debilitating effects of mental health conditions, and the burden is increasing. Meanwhile, we continue to recycle the same short list of modestly effective, side-effect inducing drugs. We can do better.
The Neuroscape Psychedelics Division is dedicated to advancing the field of psychedelic science and medicine through multi-level research covering basic to translational to clinical science. Our research is dedicated to the delivery of breakthrough discoveries in psychiatry, neurology and neuroscience.
Director, Psychedelics Division